Roivant Sciences Ltd.

Insider Reports History

Entity
Company
Location
Clarendon House, 2 Church Street, Hamilton Hm11, Bermuda
Signature
/s/ Matt Maisak, as Authorized Signatory
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roivant Sciences Ltd.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Immunovant, Inc. Director, 10%+ Owner Common Stock, $0.0001 par value per share 79,805,331 $3.03 B $38.00 Oct 2, 2023 Direct
Arbutus Biopharma Corp 10%+ Owner Common shares, without par value 38,847,462 Oct 18, 2021 Direct
Arbutus Biopharma Corp 10%+ Owner Series A participating convertible preferred shares 0 Oct 18, 2021 Direct

Insider Reports Filed by Roivant Sciences Ltd.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMVT Immunovant, Inc. Oct 2, 2023 2 228,000,000 4 Oct 4, 2023 Director, 10%+ Owner
IMVT Immunovant, Inc. Oct 6, 2022 1 2,500,002 4 Oct 7, 2022 10%+ Owner
ABUS Arbutus Biopharma Corp Oct 18, 2021 2 0 4 Oct 20, 2021 10%+ Owner
IMVT Immunovant, Inc. Aug 2, 2021 1 0 4 Aug 2, 2021 10%+ Owner